Generate Life Sciences Establishes Newborn Stem Cell Manufacturing Facility to Support Personalized Therapeutics Development

Generate Life Sciences (Generate) today announced the establishment of its Good Manufacturing Practice (GMP) facility in La Jolla, California which will enable end-to-end manufacturing for newborn stem cell biologics. This facility will represent a big step in the evolution of Generate and...

Evotec to Partner with GCKD Study to Facilitate Molecular Analysis of Patient Samples

Evotec SE and the University Hospital Erlangen just announced a partnership regarding molecular analyses of biospecimens from the German Chronic Kidney Disease ("GCKD") cohort study. Under the agreement, the research team will make use of Evotec's proprietary EVOpanOmics and EVOpanHunter platforms to...
Metabio

The Need for Patient-Pushed, Real-World Data on Neurodegenerative Diseases

Neurodegenerative diseases, is a collective term for a group of disorders characterized by the progressive neurodegeneration of brain cells, leading to dysfunction(s) and abnormal structure(s) in the central and/or peripheral nervous systems. One of the main causes of neurodegeneration...

Large Study on Mental Health Genetics Launched by Estonian Biobank

Nearly every second individual is affected by a mental health problem in their lifetime, but the exact mechanisms causing these problems remain unclear. To bring more clarity to the field of mental health, the Estonian Biobank at the University...

New Collaboration to Discover and Develop Precision Medicines for Chronic Kidney Diseases

Collaboration will Leverage Access to the NURTuRE Patient Biobank and Evotec’s PanHunter Multi-Omics Platform to Characterize Molecular Drivers, Identify and Validate Novel Targets and Drive Patient Stratification Strategies in Kidney Disease Collaboration Will Focus on Polycystic Kidney Disease...

Prediction for Inflammatory Bowel Diseases Could be Improved with Multi-Population Risk Scores

Using genetic data from nearly 30,000 people, Mount Sinai researchers have built risk scores from a combination of datasets representing distinct ancestral populations that improve prediction of risk for inflammatory bowel diseases (IBD) including Crohn's disease and ulcerative colitis....

How Biobanks Can Support Personalized Medicine

Biobanks should be an integral part of a comprehensive research platform, not exclusively viewed as a service provider or freezer farm managed with excel sheets. For biobanks to be be viewed as a contributing partner and one that can...

Regeneron to Sequence DNA Samples from UTHSC Biorepository in a Collaboration for Advancing Precision...

The University of Tennessee Health Science Center has entered into an agreement with the Regeneron Genetics Center, a subsidiary of Regeneron Pharmaceuticals, Inc., for the company to sequence DNA that has been voluntarily collected and stored as part of...

Colorectal Cancer: A Biobank of Patient-derived Xenografts

According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. There were nearly 2 million new cases and about 1 million deaths in 2018. The incidence of...

Thermo Fisher Scientific Announces Collaborations to Meet Unmet Clinical Needs in Biomarker Discovery and...

CAMBRIDGE, Mass – (September 14, 2020) – Thermo Fisher Scientific, the world leader in serving science, today announced new collaborations of the Thermo Fisher Precision Medicine Science Center (PMSC) with AstraZeneca and the University of Nebraska Medical Center as part...

⭐ Recently Featured

🔥 Popular Posts

X